Role of major histocompatibility complex class I antigens in modulating the performance of murine tumour cells in cold target competition assays.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7890307PMCID PMC1415178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MHC class I up-regulation protects some but not all targets against LAK-mediated lysis: possible implications for the existence of LAK cell subpopulations using different recognition strategies.

  1993cited by this paper
• Quantitative estimation of major histocompatibility complex antigens on live tumour cells.

  1990cited by this paper
• Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.

  1990cited by this paper
• In search of the 'missing self': MHC molecules and NK cell recognition.

  1990cited by this paper
• Interleukin-2-induced decrease in the buoyant density of cytotoxic cells and its relationship with proliferation.

  1989cited by this paper
• Properties and characterization of a rat spleen cell-derived factor that induces resistance to natural killer cell lysis in YAC lymphoma cells.

  1988cited by this paper
• Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.

  1988cited by this paper
• Interferon-gamma reduces the sensitivity of cultured and fresh human tumor cells to lysis by lymphokine-activated killer cells.

  1988cited by this paper
• Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen.

  1987cited by this paper
• Effect of immunotherapy with allogeneic lymphokine-activated killer cells and recombinant interleukin 2 on established pulmonary and hepatic metastases in mice.

  1986cited by this paper
• Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

  1986cited by this paper
• Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

  1984cited by this paper
• Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.

  1982cited by this paper
• Modulation of target cell susceptibility to human natural killer cells by interferon

  1980cited by this paper

• IFN-γ Inhibits IL-4–Induced Type 2 Cytokine Expression by CD8 T Cells In Vivo and Modulates the Anti-Tumor Response

  2010cites this paper
• The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model

  2006cites this paper
• Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures.

  2004cites this paper
• Regulation of CD1d expression by murine tumor cells: Escape from immunosurveillance or alternate target molecules?

  2002cites this paper
• Participation of CD45, NKR-P1A and ANK61 antigen in rat hepatic NK cell (pit cell)mediated target cell cytotoxicity.

  2000cites this paper
• Molecular biology of liver disorders:the hepatitis C virus and molecular targets for drug development.

  2000cites this paper
• Tumor specific boosting of IL-2 induced NK activation by paraformaldehyde fixed tumor cells.

  1998cites this paper
• The mode of presentation and route of administration are critical for the induction of immune responses to p53 and antitumor immunity.

  1998cites this paper
• Cytokine regulation of expression of class I MHC antigens

  1998cites this paper
• Mechanism of interaction of pH 3.0 treated tumor cells expressing lower levels of class I MHC antigens, with IL-2 activated NK cells.

  1997cites this paper
• Missing self by heterogeneous natural killer cells

  1997influential citation
• Ontogeny of inhibitory receptors for MHC molecules on NK cells.

  1997cites this paper
• In vitro and in vivo recovery of IFN-gamma, but not IL-2, production by IL-12 in mice with plasma cell tumors.

  1996cites this paper
• A study of the effects of irradiation and interferon-γ on susceptibility to lymphokine activated killer cells and cytotoxic T lymphocytes

  1996cites this paper
• Enhanced MHC I antigen expression on tumour target cells is inversely correlated to lysis by allogenic but not by xenogenic NK cells

  1995cites this paper
• Regulation of NK susceptibility by target cell class I MHC molecules.

  1995cites this paper